|
Meet the media partners...
|
Espicom
|
|
 Published by Espicom Business Intelligence, Pharma Company Insight (PCI) is the weekly business publication, which provides the latest news and developments involving pharmaceutical companies worldwide. A subscription delivers real commercial advantage and is the cost-effective, time-saving way to stay in touch with the market.
For further information and to start your subscription today, go to: www.espicom.com/pci
 Published by Espicom Business Intelligence, Pharma Agreement News is the twice-monthly business publication that concisely reports on hundreds of agreements and deals between phamaceutical companies worldwide.
For further information and to order your subscription today, visit www.espicom.com/pan
|
|
Samedan
|
|
 International Clinical Trials (ICT) is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector. Published quarterly, the journal offers a platform of communication and information-sharing for executive and strategic decision-makers, seeking out new trends and marketing opportunities, as well as putting a spotlight on the latest innovations coming to market. Every issue, 10,500 copies are distributed to our specially targeted readership of strategic decision-makers within pharmaceutical companies and their contract partners, primarily in Europe, but increasingly to North America and the rest of the world.
For further information, please contact John White, john@samedanltd.com (editorial), David Hirsh, david@samedanltd.com (sales), or call 020 7724 3456.
 The European Pharmaceutical Contractor (EPC) continually provides a dedicated platform of communication and information for the international pharmaceutical contract market. Edited by Dr Graham Hughes and established in 1997, each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. Every issue, 10,500 copies of the magazine are distributed to our specially targeted readership across the world.
For further information, please contact Ed Swan, ed@samedanltd.com (editorial), Jonathan Smith, jonathan@samedanltd.com (sales), or call 020 7724 3456.
www.samedan.com
|
|
Expert Review Clinical Pharmacology
|
|
 Advances in drug development technologies are yielding innovative new therapies, from potentially lifesaving medicines to lifestyle products. In recent years, however, the cost of developing new drugs has soared, and concerns over drug resistance and pharmacoeconomics have come to the fore. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery.
Clinical pharmacology provides an essential role in integrating the expertise of all of the specialists and players who are active in meeting such challenges in modern biomedical practice.
Expert Review of Clinical Pharmacology provides a forum for informed debate and critical analysis of all aspects of safety, tolerability, efficacy and therapeutic applications, in addition to covering toxicity issues, adverse reactions, pharmacoeconomics and societal issues.
www.expert-reviews.com/loi/ecp
|
|
Expert Opinion
|
|
 
Make Better Research Decisions, Faster, with an Expert Opinion…
The Expert Opinion series of journals provide systematic and authoritative analysis to support every stage in the pharmaceutical pipeline. With 11 internationally peer-reviewed journals, we cover the full spectrum of drug development and application.
11 phase-specific journals:
• Expert Opinion on Biological Therapy
• Expert Opinion on Drug Delivery
• Expert Opinion on Drug Discovery
• Expert Opinion on Drug Metabolism & Toxicology
• Expert Opinion on Drug Safety
• Expert Opinion on Emerging Drugs
• Expert Opinion on Investigational Drugs
• Expert Opinion on Medical Diagnostics
• Expert Opinion on Pharmacotherapy
• Expert Opinion on Therapeutic Patents
• Expert Opinion on Therapeutic Targets
Our expertly crafted review articles enable the R&D community to access and track the key advances that lead to the creation of new drugs.
The distinctive “Expert Opinion” section within each review provides a personal commentary from the author on the most effective and promising strategies: an invaluable resource for decision-makers in the field.
30-day Free Trial for you, and your colleagues…
For more information and to apply for a Free 30-day Trial for your organization visit www.expertopin.com, email expertopin@informa.com or call +44 (0)20 3377 3310 today!
|
|
Bio Spectrum Asia
|
|
BioSpectrum Asia is a unique, integrated B2B media platform of print, digital, online and events. It engages its readers from Life-Sciences industry (Pharma, Biotech & Medtech) across Asia pacific region on a Daily/Fortnightly/Monthly through its media products and services.
BioSpectrum Asia started, as first Business life-science industry magazine with an objective to create a platform for growing Asia-pacific life sciences industry and is today the largest distributed Pan-Asia Life-Sciences industry magazine.
The magazine is published, printed and distributed from Singapore by Cyber Media (Singapore) Pte Limited.
About Print magazine
Print edition is distributed monthly across Asia-pacific region covering pharma, biotech and medtech featuring News, articles, interviews, policies, products, events and issues impacting the industry in the regions.
About Digital magazine
Digital magazine is crisp, online, and easy to use, new age media which picks up an issue, segment or country every fortnightly covering the impact it has on the Asia Pacific life-sciences industry. It is delivered on 10th and the 26th of every month subscribers’ desktop to read it online or download for reading it at their convenience
About Portal www.biospectrumasia.com
www.biospectrumasia.com is a portal updated daily providing rich content for life sciences industry in Asia Pacific region. Easy navigation by country (Key countries in Asia Pacific region) and by sector (Pharma, Biotech and Medical devices) makes it interesting for the readers to get on to relevant information quickly.
|
|
Markets and Markets
|
|
 MarketsandMarkets is a full service and consulting firm that produces strategically analyzed full length reports track more than 10 industries. By FYE 2010 M&M plans to launch industry-wise and country wise market tracker for all the verticals tracked. This intelligence database comprising of about 60000 reports a year will form one of the world's largest intelligence resources worldwide. MarketsandMarkets has effectively used technology to automate management of large and complex data for forecasts. MarketsandMarkets aspires to help its client to achieve sustainable growth by providing incisive business insights into their respective business partners. Our 200 global strategic accounts with topline revenues in excess of USD 1 Billion annually. Delivered syndicated research studies to top publishers globally on a subcontracting model. The major industries that we cover in our market intelligence deliverables are Pharma & Biotech, Telecom & IT, Healthcare & Life sciences, Chemical & Advanced Material, Electronics & Semiconductor, and Foods & Beverages.
Visit: www.marketsandmarkets.com
|
|
The Big Red Biotech Blog
|
|
 News and discussion on critical trends and issues in the biopharm and pharmaceutical industry. Commentary on current events,clinical pipelines, facility expansions, competition, technology, legal and economic issues. M&A activity throughout the globe.
I am the Director of Development for SAFC. The views expressed in this blog are my own. I am not speaking officially for SAFC or Sigma-Aldrich Corporation. I'd like to engage industry participants in conversations. I want to hear your views - both with regard to my posts & what you think is important that I may be omitting. Commentary is encouraged.
http://thebigredbiotechblog.typepad.com/the-big-red-biotech-blog/
|
|
Meet the Boss TV
|
|
 Become the complete executive with exclusive video and audio lessons from the world’s most innovative and influential business leaders. Get to the top, fast.
From visionary entrepreneurs to Fortune 500 CEOs, MeetTheBoss TV interviews focus on the business challenges that matter today, clearly explaining the solutions, competitive strategies, people, and thinking around them.
These lessons add to your skills set, giving you the tools you need to make a difference – both professionally and personally. www.meettheboss.tv
|
|
Next Generation Pharmaceutical
|
|
 Pharmaceutical companies are currently facing unprecedented pressures, including dry pipelines and a dearth of new blockbusters. A large percentage of drug development fails in the late stages of phase III, while the cost of getting a new drug to market continues to rise. Next Generation Pharmaceutical Europe features insight and analysis from senior industry executives on current trends in drug development, clinical trials, technology, business and manufacturing, helping companies to navigate these challenging times.
Next Generation Pharmaceutical Europe is a print and online publication that caters for C-level executives and decision-makers. It is published quarterly, with a controlled circulation. http://www.ngpharma.eu.com/
|
|
ClinPage
|
|
 ClinPage is an online newsletter about technologies and services in clinical trials. Its coverage is daily and definitive. Articles and podcasts at ClinPage (www.clinpage.com) showcase thought leaders in the industry who help our editors analyze pivotal trends. Key topics include outsourcing, electronic data capture, contract research organizations, global trials, clinical data management, drug safety, FDA policy, clinical data standards, patient-reported outcomes and adaptive trial designs. ClinPage was founded in 2006 by Mark Uehling, an award-winning technology journalist and former editor of BioIT World.
www.clinpage.com
|
|
Bentham Science
|
|
 Bentham Science Publishers, a major STM journal publisher of 90 titles and more than 200 open access journals in 2009, answers the information needs of the pharmaceutical, bio and medical research community. Leading journals include Current Molecular Medicine (Impact Factor 5.254) and Current Medicinal Chemistry (Impact Factor 4.823) :
• FREE online journals and information: www.bentham.org
• Subscribe, Consortia, discounted global licenses and trials: marketing@bentham.org
To know more about our publications please visit : http://bentham.org/Titlesbydiscipline.htm
|
Press releases / editorial
Event previews - If you would like to preview Exploratory Clinical Development World Europe 2010 please contact Julie Phillips directly giving your deadline dates and requirements. If you would like to receive more in-depth information, or would like a bespoke article, I will also be happy to supply this for you.
Press registration - Qualified press are eligible to attend the Exploratory Clinical Development World Europe 2010 on a complimentary press pass. In order to qualify for a press pass, please contact Julie Phillips. All fields must be completed in order for your press registration to be considered.
** Please note: after we have received your credentials, they will be reviewed and are subject to approval based on press space allocation and management’s discretion. If approved, you will receive an e-mail confirming your registration status. Thank you.
|
| |
|
|
©Terrapinn Holdings Ltd. MMX
